Drug General Information |
Drug ID |
D02PVB
|
Former ID |
DNC002874
|
Drug Name |
2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C14H8N2O
|
Canonical SMILES |
C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O
|
InChI |
1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16)
|
InChIKey |
ACPOUJIDANTYHO-UHFFFAOYSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
117321, 3144734, 3308697, 3724860, 3967281, 4726008, 5604123, 7885383, 7980045, 8156016, 10318986, 11111809, 11114107, 11120216, 11120704, 11121192, 11121718, 11122198, 11147299, 11362820, 11365382, 11367944, 11370871, 11370872, 11373545, 11376106, 15172126, 17405036, 24278395, 26536949, 26752203, 26752204, 26758988, 26758995, 29227191, 46392887, 46507936, 46509480, 47440505, 47440506, 47515564, 47589208, 47662529, 47736732, 48110706, 48110707, 48185213, 49830715, 49870568, 50104867
|
Target and Pathway |
Target(s) |
Mitogen-activated protein kinase 8 |
Target Info |
Inhibitor |
[1]
|
Dual specificity protein kinase TTK |
Target Info |
Inhibitor |
[1]
|
Mitogen-activated protein kinase 10 |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
MAPK signaling pathway
|
ErbB signaling pathway
|
Ras signaling pathway
|
cAMP signaling pathway
|
FoxO signaling pathway
|
Sphingolipid signaling pathway
|
Protein processing in endoplasmic reticulum
|
Wnt signaling pathway
|
Osteoclast differentiation
|
Focal adhesion
|
Toll-like receptor signaling pathway
|
NOD-like receptor signaling pathway
|
RIG-I-like receptor signaling pathway
|
Fc epsilon RI signaling pathway
|
TNF signaling pathway
|
Neurotrophin signaling pathway
|
Retrograde endocannabinoid signaling
|
Dopaminergic synapse
|
Inflammatory mediator regulation of TRP channels
|
Insulin signaling pathway
|
GnRH signaling pathway
|
Progesterone-mediated oocyte maturation
|
Prolactin signaling pathway
|
Adipocytokine signaling pathway
|
Type II diabetes mellitus
|
Non-alcoholic fatty liver disease (NAFLD)
|
Epithelial cell signaling in Helicobacter pylori infection
|
Shigellosis
|
Salmonella infection
|
Pertussis
|
Chagas disease (American trypanosomiasis)
|
Toxoplasmosis
|
Tuberculosis
|
Hepatitis C
|
Hepatitis B
|
Influenza A
|
HTLV-I infection
|
Herpes simplex infection
|
Epstein-Barr virus infection
|
Pathways in cancer
|
Colorectal cancer
|
Pancreatic cancer
|
Choline metabolism in cancerhsa04110:Cell cyclehsa04010:MAPK signaling pathway
|
Choline metabolism in cancer
|
NetPath Pathway
|
IL5 Signaling Pathway
|
TNFalpha Signaling PathwayNetPath_14:IL2 Signaling Pathway
|
PANTHER Pathway
|
Alzheimer disease-amyloid secretase pathway
|
Angiogenesis
|
Apoptosis signaling pathway
|
B cell activation
|
FAS signaling pathway
|
Integrin signalling pathway
|
Interferon-gamma signaling pathway
|
Oxidative stress response
|
PDGF signaling pathway
|
Parkinson disease
|
TGF-beta signaling pathway
|
T cell activation
|
Toll receptor signaling pathway
|
Ras Pathway
|
CCKR signaling map STP00003:Alzheimer disease-amyloid secretase pathway
|
EGF receptor signaling pathway
|
FGF signaling pathway
|
CCKR signaling map ST
|
Pathway Interaction Database
|
Fc-epsilon receptor I signaling in mast cells
|
Endothelins
|
BCR signaling pathway
|
RhoA signaling pathway
|
Noncanonical Wnt signaling pathway
|
CD40/CD40L signaling
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
Osteopontin-mediated events
|
Reelin signaling pathway
|
TRAIL signaling pathway
|
CDC42 signaling events
|
Signaling events regulated by Ret tyrosine kinase
|
Angiopoietin receptor Tie2-mediated signaling
|
FAS (CD95) signaling pathway
|
IL1-mediated signaling events
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
Glucocorticoid receptor regulatory network
|
IL2-mediated signaling events
|
Rapid glucocorticoid signaling
|
FoxO family signaling
|
Ceramide signaling pathway
|
Regulation of Androgen receptor activity
|
p75(NTR)-mediated signaling
|
ErbB1 downstream signaling
|
ATF-2 transcription factor network
|
ErbB2/ErbB3 signaling events
|
PDGFR-beta signaling pathway
|
JNK signaling in the CD4+ TCR pathway
|
Nephrin/Neph1 signaling in the kidney podocyte
|
HIV-1 Nef: Negative effector of Fas and TNF-alpha
|
Retinoic acid receptors-mediated signaling
|
Signaling events mediated by Stem cell factor receptor (c-Kit)
|
EPO signaling pathway
|
Syndecan-2-mediated signaling events
|
Ephrin B reverse signaling
|
p53 pathway
|
N-cadherin signaling events
|
S1P2 pathway
|
Downstream signaling in naï
|
RAC1 signaling pathway
|
Signaling events mediated by focal adhesion kinase
|
Glypican 3 network
|
IL12 signaling mediated by STAT4wnt_noncanonical_pathway:Noncanonical Wnt signaling pathway
|
PathWhiz Pathway
|
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
|
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
Reactome
|
NRAGE signals death through JNK
|
NRIF signals cell death from the nucleus
|
Oxidative Stress Induced Senescence
|
FCERI mediated MAPK activation
|
DSCAM interactions
|
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
|
Activation of the AP-1 family of transcription factors
|
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksR-HSA-2559580:Oxidative Stress Induced Senescence
|
WikiPathways
|
Toll-like receptor signaling pathway
|
DNA Damage Response (only ATM dependent)
|
TCR Signaling Pathway
|
ErbB Signaling Pathway
|
Insulin Signaling
|
EGF/EGFR Signaling Pathway
|
MAPK Signaling Pathway
|
TGF beta Signaling Pathway
|
FAS pathway and Stress induction of HSP regulation
|
Signaling of Hepatocyte Growth Factor Receptor
|
Kit receptor signaling pathway
|
Transcriptional activation by NRF2
|
NLR Proteins
|
IL-3 Signaling Pathway
|
Cardiac Hypertrophic Response
|
Nanoparticle-mediated activation of receptor signaling
|
Structural Pathway of Interleukin 1 (IL-1)
|
EBV LMP1 signaling
|
JAK/STAT
|
PDGF Pathway
|
Nanoparticle triggered regulated necrosis
|
BDNF signaling pathway
|
Integrated Pancreatic Cancer Pathway
|
Oncostatin M Signaling Pathway
|
Corticotropin-releasing hormone
|
AGE/RAGE pathway
|
TNF alpha Signaling Pathway
|
B Cell Receptor Signaling Pathway
|
Prostate Cancer
|
TSLP Signaling Pathway
|
TWEAK Signaling Pathway
|
Leptin signaling pathway
|
RANKL/RANK Signaling Pathway
|
Signalling by NGF
|
IL-1 signaling pathway
|
Intrinsic Pathway for Apoptosis
|
DSCAM interactions
|
Apoptosis Modulation and Signaling
|
Type II diabetes mellitus
|
MicroRNAs in cardiomyocyte hypertrophy
|
Physiological and Pathological Hypertrophy of the Heart
|
Regulation of toll-like receptor signaling pathway
|
Osteoclast SignalingWP2446:Retinoblastoma (RB) in CancerWP75:Toll-like receptor signaling pathway
|
G13 Signaling Pathway
|
Wnt Signaling Pathway
|
MAPK Cascade
|
Oxidative Stress
|
Wnt Signaling Pathway and Pluripotency
|
Apoptosis Modulation by HSP70
|
Apoptosis
|
Integrin-mediated Cell Adhesion
|
References |
REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |